Skip to main content

Advertisement

Figure 3 | Clinical Proteomics

Figure 3

From: Potential tumor biomarkers identified in ovarian cyst fluid by quantitative proteomic analysis, iTRAQ

Figure 3

Immunoblot validation of SAA4 and ASTL in 68 cyst fluid samples with mixed histology. Protein concentration in cyst fluid in benign, stage I-II, and stage III-IV for A) SAA4, malignant samples displayed a significantly higher expression than benign (p=0.001). B) ASTL, significantly increased expression in malignant samples (p=0.003) were in contrast to the iTRAQ results. C) Total protein, significantly higher in the malignant cohort compared to the benign (p=0.02). D) Immunoblot expression SAA4 and ASTL in cyst fluid and plasma. In plasma there was no significant difference between benign and malignant samples for either SAA4 nor ASTL.

Back to article page